Insulet PODD
NASDAQ PODD
$134.90 -3.02 (-2.19%)
As of: Sep 10, 2026 · 2:52 PM EDT

Insulet (PODD) Amortization of Deferred Charges (2010 - 2026)

Insulet's (PODD) quarterly Amortization of Deferred Charges came in at $700000.0 in Q2 2026, up 75.0% on a YoY basis from $400000.0 in Q2 2025, and little changed quarter-over-quarter from $700000.0 in Q1 2026.

Analysis

Insulet (PODD) Amortization of Deferred Charges (2010 - 2026) Analysis & Trends

Insulet (PODD) has reported Amortization of Deferred Charges for 17 consecutive years, with $700000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Amortization of Deferred Charges rose 75.0% year-over-year to $700000.0; the trailing twelve-month figure through Jun 2026 stood at $3.9 million (down 30.36% YoY), and the FY2025 full-year result was $6.2 million, down 15.07% from the prior year.
  • Amortization of Deferred Charges steadied at $700000.0 in Q2 2026 per PODD's latest filing, from $700000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $2.5 million in Q1 2025 and bottomed at $400000.0 in Q2 2025.
  • Historically, Amortization of Deferred Charges has averaged $1.3 million across 5 years, with a median of $1.2 million in 2022.
  • The sharpest annual moves came in 2022 and 2025: Amortization of Deferred Charges tumbled 87.29% in 2022, then jumped 112.5% in 2025.
  • Over 5 years, Amortization of Deferred Charges stood at $1.5 million in 2022, then soared by 40.0% to $2.1 million in 2023, then decreased by 9.52% to $1.9 million in 2024, then slumped by 57.89% to $800000.0 in 2025, then slipped by 12.5% to $700000.0 in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $700000.0, $700000.0, and $800000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.76 Bn 175.16 Bn 7.27 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn
3 Medtronic 117.20 Bn 108.39 Bn 6.34 Bn
4 Stryker 104.01 Bn 100.53 Bn 4.50 Bn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn
6 Edwards Lifesciences 49.80 Bn 45.55 Bn 1.35 Bn
7 Alcon 33.03 Bn 31.58 Bn 1.68 Bn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn
10 Insulet 9.35 Bn 8.82 Bn 562.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 700,000.00
Mar 31, 2026 700,000.00
Dec 31, 2025 800,000.00
Sep 30, 2025 1.70 Mn
Jun 30, 2025 400,000.00
Mar 31, 2025 2.50 Mn
Dec 31, 2024 1.90 Mn
Sep 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Mar 31, 2024 2.00 Mn
Dec 31, 2023 2.10 Mn
Sep 30, 2023 700,000.00
Jun 30, 2023 1.20 Mn
Mar 31, 2023 1.50 Mn
Dec 31, 2022 1.50 Mn
Sep 30, 2022 1.10 Mn
Jun 30, 2022 1.00 Mn
Mar 31, 2022 1.50 Mn
Dec 31, 2021 8.30 Mn
Sep 30, 2021 900,000.00